Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice
Open Access
- 16 August 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Research
- Vol. 22 (3), 516-527
- https://doi.org/10.1038/cr.2011.132
Abstract
Recent studies have begun to reveal critical roles of microRNAs (miRNAs) in the pathogenesis of cardiac hypertrophy and dysfunction. In this study, we tested whether a transforming growth factor-β (TGF-β)-regulated miRNA played a pivotal role in the development of cardiac hypertrophy and heart failure (HF). We observed that miR-27b was upregulated in hearts of cardiomyocyte-specific Smad4 knockout mice, which developed cardiac hypertrophy. In vitro experiments showed that the miR-27b expression could be inhibited by TGF-β1 and that its overexpression promoted hypertrophic cell growth, while the miR-27b suppression led to inhibition of the hypertrophic cell growth caused by phenylephrine (PE) treatment. Furthermore, the analysis of transgenic mice with cardiomyocyte-specific overexpression of miR-27b revealed that miR-27b overexpression was sufficient to induce cardiac hypertrophy and dysfunction. We validated the peroxisome proliferator-activated receptor-γ (PPAR-γ) as a direct target of miR-27b in cardiomyocyte. Consistently, the miR-27b transgenic mice displayed significantly lower levels of PPAR-γ than the control mice. Furthermore, in vivo silencing of miR-27b using a specific antagomir in a pressure-overload-induced mouse model of HF increased cardiac PPAR-γ expression, attenuated cardiac hypertrophy and dysfunction. The results of our study demonstrate that TGF-β1-regulated miR-27b is involved in the regulation of cardiac hypertrophy, and validate miR-27b as an efficient therapeutic target for cardiac diseases.Keywords
This publication has 44 references indexed in Scilit:
- MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA DestabilizationJournal of Biological Chemistry, 2010
- microRNA miR-27b impairs human adipocyte differentiation and targets PPARγBiochemical and Biophysical Research Communications, 2009
- Adaptive and Maladptive Effects of SMAD3 Signaling in the Adult Heart After Hemodynamic Pressure OverloadingCirculation: Heart Failure, 2009
- miR-23a functions downstream of NFATc3 to regulate cardiac hypertrophyProceedings of the National Academy of Sciences, 2009
- Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosisProceedings of the National Academy of Sciences, 2008
- Transforming growth factor- -regulated miR-24 promotes skeletal muscle differentiationNucleic Acids Research, 2008
- Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failureProceedings of the National Academy of Sciences, 2008
- MicroRNA-133 controls cardiac hypertrophyNature Medicine, 2007
- A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failureProceedings of the National Academy of Sciences, 2006
- Overexpression of Bone Morphogenetic Protein 10 in Myocardium Disrupts Cardiac Postnatal Hypertrophic GrowthPublished by Elsevier BV ,2006